Terminal ballistics of kinase inhibitors: there are no magic bullets.
Maitland
Michael L
ML
Ratain
Mark J
MJ
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D011505:Protein-Tyrosine Kinases